Status:
COMPLETED
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
Lead Sponsor:
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Conditions:
Brain and Central Nervous System Tumors
Long-term Effects Secondary to Cancer Therapy in Children
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identi...
Detailed Description
OBJECTIVES: Primary * Identify all applied therapy strategies in pediatric patients with craniopharyngioma. * Correlate relapse status with different therapy strategies/modality in these patients. *...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of primary craniopharyngioma by MRI and CT scan (initial diagnosis)
- Patients with only cystic sellar or parasellar malformation (e.g., Rathke pouch cysts or suprasellar cysts) are allowed but will undergo observation only
- PATIENT CHARACTERISTICS:
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- PRIOR CONCURRENT THERAPY: Not specified
Exclusion
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00258453
Start Date
May 1 2001
End Date
September 1 2009
Last Update
August 2 2013
Active Locations (109)
Enter a location and click search to find clinical trials sorted by distance.
1
Krankenhaus Dornbirn
Dornbirn, Austria, A-6850
2
Landeskrankenhaus Feldkirch
Feldkirch-Tisis, Austria, A-6807
3
Universitaet Kinderklinik
Graz, Austria, 8036
4
Innsbruck Universitaetsklinik
Innsbruck, Austria, A-6020